Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

gilead sciences ireland uc - sofosbuvir - hepatitida c, chronická - antivirotika pro systémové použití - sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 a 5. pro virus hepatitidy c (hcv) genotypu konkrétní činnosti, viz bod 4. 4 a 5. sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adults and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 a 5. pro virus hepatitidy c (hcv) genotypu konkrétní činnosti, viz bod 4. 4 a 5.

Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - glecaprevir, pibrentasvir - hepatitida c, chronická - antivirotika pro systémové použití - maviret is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults and children aged 3 years and older. maviret coated granules is indicated for the treatment of chronic hepatitis c virus (hcv) infection in children 3 years and older.

Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

gilead sciences ireland uc - sofosbuvir, velpatasvir, voxilaprevi - hepatitida c, chronická - antivirotika pro systémové použití - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (viz body 4. 2, 4. 4 a 5.

Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

theramex ireland limited - teriparatid - osteoporóza - vápníková homeostáza - livogiva is indicated in adults. léčba osteoporózy u postmenopauzálních žen a u mužů se zvýšeným rizikem zlomenin. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. léčba osteoporózy spojené s trvalou terapií systémovými glukokortikoidy u žen a mužů se zvýšeným rizikem zlomenin.

Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

mylan ireland limited - sugammadex sodium - neuromuskulární blokáda - všechny ostatní terapeutické přípravky - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, typ 2 - léky užívané při diabetu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. trojkombinační léčbě) jako doplněk k dietním opatřením a cvičení u pacientů nedostatečně maximální tolerované dávky metforminu a sulfonylmočoviny. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulární blokáda - všechny ostatní terapeutické přípravky - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - imunosupresiva - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).

Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

herbacos recordati s.r.o., pardubice array - 12 kyselina acetylsalicylovÁ; 102 kyselina askorbovÁ - Šumivá tableta - 320mg/200mg - kyselina acetylsalicylovÁ, kombinace kromĚ psycholeptik

Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

teva pharmaceuticals cr, s.r.o., praha array - 16671 monohydrÁt natrium-alendronÁtu; 402 cholekalciferol - tableta - 70mg/0,14mg - kyselina alendronovÁ a cholekalciferol